References analysis of the Wikipedia article "Causes and origins of Tourette syndrome" in the English version

archive.org

doi.org

Robertson MM (March 2000). "Tourette syndrome, associated conditions and the complexities of treatment". Brain. 123 (3): 425–62. doi:10.1093/brain/123.3.425. PMID 10686169.

Zinner SH (November 2000). "Tourette disorder". Pediatr Rev (Review). 21 (11): 372–83. doi:10.1542/pir.21-11-372. PMID 11077021. S2CID 7774922.

Paschou P, Fernandez TV, Sharp F, Heiman GA, Hoekstra PJ (2013). "Genetic susceptibility and neurotransmitters in Tourette syndrome". Int. Rev. Neurobiol. International Review of Neurobiology. 112: 155–77. doi:10.1016/B978-0-12-411546-0.00006-8. ISBN 9780124115460. PMC 4471172. PMID 24295621.

Fernandez TV, State MW, Pittenger C (2018). "Tourette disorder and other tic disorders". In Daniel H. Geschwind, Henry L. Paulson, Christine Klein (eds.). Neurogenetics, Part I (Review). Handbook of Clinical Neurology. Vol. 147. Elsevier. pp. 343–54. doi:10.1016/B978-0-444-63233-3.00023-3. ISBN 9780444632333. PMID 29325623.

Dale RC (December 2017). "Tics and Tourette: a clinical, pathophysiological and etiological review". Curr. Opin. Pediatr. (Review). 29 (6): 665–73. doi:10.1097/MOP.0000000000000546. PMID 28915150. S2CID 13654194.

Baldermann JC, Schüller T, Huys D, et al. (2016). "Deep brain stimulation for Tourette syndrome: a systematic review and meta-analysis". Brain Stimul (Review). 9 (2): 296–304. doi:10.1016/j.brs.2015.11.005. PMID 26827109. S2CID 22929403.

Cavanna AE (November 2018). "The neuropsychiatry of Gilles de la Tourette syndrome: The état de l'art". Rev. Neurol. (Paris) (Review). 174 (9): 621–27. doi:10.1016/j.neurol.2018.06.006. PMID 30098800. S2CID 51966823.

Efron D, Dale RC (October 2018). "Tics and Tourette syndrome". J Paediatr Child Health (Review). 54 (10): 1148–53. doi:10.1111/jpc.14165. hdl:11343/284621. PMID 30294996. S2CID 52934981.

Bloch M, State M, Pittenger C (April 2011). "Recent advances in Tourette syndrome". Curr. Opin. Neurol. (Review). 24 (2): 119–25. doi:10.1097/WCO.0b013e328344648c. PMC 4065550. PMID 21386676.

Stern JS (August 2018). "Tourette's syndrome and its borderland" (PDF). Pract Neurol (Historical review). 18 (4): 262–70. doi:10.1136/practneurol-2017-001755. PMID 29636375. S2CID 4709096.

Paschou P (July 2013). "The genetic basis of Gilles de la Tourette Syndrome". Neurosci Biobehav Rev (Review). 37 (6): 1026–39. doi:10.1016/j.neubiorev.2013.01.016. PMID 23333760. S2CID 10515751.

Barnhill J, Bedford J, Crowley J, Soda T (2017). "A search for the common ground between Tic; Obsessive-compulsive and Autism Spectrum Disorders: part I, Tic disorders". AIMS Genet (Review). 4 (1): 32–46. doi:10.3934/genet.2017.1.32. PMC 6690237. PMID 31435502.

Mejia NI, Jankovic J (March 2005). "Secondary tics and tourettism" (PDF). Braz J Psychiatry. 27 (1): 11–7. doi:10.1590/s1516-44462005000100006. PMID 15867978. Archived from the original (PDF) on June 28, 2007.

Peterson B, Riddle MA, Cohen DJ, et al. (May 1993). "Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images". Neurology. 43 (5): 941–9. doi:10.1212/wnl.43.5.941. PMID 8492950. S2CID 11641251.

Moriarty J, Varma AR, Stevens J, et al. (August 1997). "A volumetric MRI study of Gilles de la Tourette's syndrome". Neurology. 49 (2): 410–5. doi:10.1212/wnl.49.2.410. PMID 9270569. S2CID 26958522.

Singer HS, Walkup JT (January 1991). "Tourette syndrome and other tic disorders. Diagnosis, pathophysiology, and treatment". Medicine (Baltimore). 70 (1): 15–32. doi:10.1097/00005792-199101000-00002. PMID 1988764. S2CID 22623671.

Singer HS, Butler IJ, Tune LE, Seifert WE, Coyle JT (October 1982). "Dopaminergic dsyfunction in Tourette syndrome". Ann. Neurol. 12 (4): 361–6. doi:10.1002/ana.410120408. PMID 6184010. S2CID 71299547.

Klawans HL, Falk DK, Nausieda PA, Weiner WJ (October 1978). "Gilles de la Tourette syndrome after long-term chlorpromazine therapy". Neurology. 28 (10): 1064–6. doi:10.1212/wnl.28.10.1064. PMID 284201. S2CID 38781188.

Butler IJ, Koslow SH, Seifert WE, Caprioli RM, Singer HS (July 1979). "Biogenic amine metabolism in Tourette syndrome". Ann. Neurol. 6 (1): 37–9. doi:10.1002/ana.410060109. PMID 292354. S2CID 12142634.

Singer HS (May 1997). "Neurobiology of Tourette syndrome". Neurol Clin. 15 (2): 357–79. doi:10.1016/s0733-8619(05)70318-2. PMID 9115467.

Rapanelli M, Pittenger C (July 2016). "Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions". Neuropharmacology. 106: 85–90. doi:10.1016/j.neuropharm.2015.08.019. PMID 26282120. S2CID 20574808.

Bolam JP, Ellender TJ (July 2016). "Histamine and the striatum". Neuropharmacology. 106: 74–84. doi:10.1016/j.neuropharm.2015.08.013. PMC 4917894. PMID 26275849.

Hollis C, Pennant M, Cuenca J, et al. (January 2016). "Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis". Health Technol Assess. 20 (4): 1–450, vii–viii. doi:10.3310/hta20040. PMC 4781241. PMID 26786936.

Robertson MM (February 2011). "Gilles de la Tourette syndrome: the complexities of phenotype and treatment". Br J Hosp Med (Lond). 72 (2): 100–07. doi:10.12968/hmed.2011.72.2.100. PMID 21378617.

Wilbur C, Bitnun A, Kronenberg S, Laxer RM, Levy DM, Logan WJ, Shouldice M, Yeh EA (May 2019). "PANDAS/PANS in childhood: Controversies and evidence". Paediatr Child Health. 24 (2): 85–91. doi:10.1093/pch/pxy145. PMC 6462125. PMID 30996598.

Sigra S, Hesselmark E, Bejerot S (March 2018). "Treatment of PANDAS and PANS: a systematic review". Neurosci Biobehav Rev. 86: 51–65. doi:10.1016/j.neubiorev.2018.01.001. PMID 29309797.

Moretti G, Pasquini M, Mandarelli G, Tarsitani L, Biondi M (2008). "What every psychiatrist should know about PANDAS: a review". Clin Pract Epidemiol Ment Health. 4 (1): 13. doi:10.1186/1745-0179-4-13. PMC 2413218. PMID 18495013.

Swain JE, Scahill L, Lombroso PJ, King RA, Leckman JF (August 2007). "Tourette syndrome and tic disorders: a decade of progress". J Am Acad Child Adolesc Psychiatry (Review). 46 (8): 947–68. doi:10.1097/chi.0b013e318068fbcc. PMID 17667475. S2CID 343916.

Hirschtritt ME, Darrow SM, et al. (January 2018). "Genetic and phenotypic overlap of specific obsessive-compulsive and attention-deficit/hyperactive subtypes with Tourette syndrome". Psychol Med. 48 (2): 279–93. doi:10.1017/S0033291717001672. PMC 7909616. PMID 28651666.

Hirschtritt ME, Lee PC, Pauls DL, et al. (April 2015). "Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome". JAMA Psychiatry. 72 (4): 325–33. doi:10.1001/jamapsychiatry.2014.2650. PMC 4446055. PMID 25671412.

Robertson MM, Eapen V, Singer HS, et al. (February 2017). "Gilles de la Tourette syndrome". Nat Rev Dis Primers (Review). 3: 16097. doi:10.1038/nrdp.2016.97. PMID 28150698. S2CID 38518566.

nih.gov

pubmed.ncbi.nlm.nih.gov

Robertson MM (March 2000). "Tourette syndrome, associated conditions and the complexities of treatment". Brain. 123 (3): 425–62. doi:10.1093/brain/123.3.425. PMID 10686169.

Zinner SH (November 2000). "Tourette disorder". Pediatr Rev (Review). 21 (11): 372–83. doi:10.1542/pir.21-11-372. PMID 11077021. S2CID 7774922.

Efron D, Dale RC (October 2018). "Tics and Tourette syndrome". J Paediatr Child Health (Review). 54 (10): 1148–53. doi:10.1111/jpc.14165. hdl:11343/284621. PMID 30294996. S2CID 52934981.

Bloch M, State M, Pittenger C (April 2011). "Recent advances in Tourette syndrome". Curr. Opin. Neurol. (Review). 24 (2): 119–25. doi:10.1097/WCO.0b013e328344648c. PMC 4065550. PMID 21386676.

Stern JS (August 2018). "Tourette's syndrome and its borderland" (PDF). Pract Neurol (Historical review). 18 (4): 262–70. doi:10.1136/practneurol-2017-001755. PMID 29636375. S2CID 4709096.

van de Wetering BJ, Heutink P (May 1993). "The genetics of the Gilles de la Tourette syndrome: a review". J. Lab. Clin. Med. (Review). 121 (5): 638–45. PMID 8478592.

Paschou P (July 2013). "The genetic basis of Gilles de la Tourette Syndrome". Neurosci Biobehav Rev (Review). 37 (6): 1026–39. doi:10.1016/j.neubiorev.2013.01.016. PMID 23333760. S2CID 10515751.

van de Wetering BJ, Heutink P (May 1993). "The genetics of the Gilles de la Tourette syndrome: a review". J. Lab. Clin. Med. 121 (5): 638–45. PMID 8478592.

Bagheri MM, Kerbeshian J, Burd L (April 1999). "Recognition and management of Tourette's syndrome and tic disorders". Am Fam Physician (Review). 59 (8): 2263–72, 2274. PMID 10221310. Archived from the original on March 31, 2005.

Haber SN, Wolfer D (1992). "Basal ganglia peptidergic staining in Tourette syndrome. A follow-up study". Adv Neurol. 58: 145–50. PMID 1414617.

Singer HS (May 1997). "Neurobiology of Tourette syndrome". Neurol Clin. 15 (2): 357–79. doi:10.1016/s0733-8619(05)70318-2. PMID 9115467.

Bolam JP, Ellender TJ (July 2016). "Histamine and the striatum". Neuropharmacology. 106: 74–84. doi:10.1016/j.neuropharm.2015.08.013. PMC 4917894. PMID 26275849.

Robertson MM (February 2011). "Gilles de la Tourette syndrome: the complexities of phenotype and treatment". Br J Hosp Med (Lond). 72 (2): 100–07. doi:10.12968/hmed.2011.72.2.100. PMID 21378617.

Sigra S, Hesselmark E, Bejerot S (March 2018). "Treatment of PANDAS and PANS: a systematic review". Neurosci Biobehav Rev. 86: 51–65. doi:10.1016/j.neubiorev.2018.01.001. PMID 29309797.

Denckla MB (2006). "Attention deficit hyperactivity disorder: the childhood co-morbidity that most influences the disability burden in Tourette syndrome". Adv Neurol (Review). 99: 17–21. PMID 16536349.

Robertson MM, Eapen V, Singer HS, et al. (February 2017). "Gilles de la Tourette syndrome". Nat Rev Dis Primers (Review). 3: 16097. doi:10.1038/nrdp.2016.97. PMID 28150698. S2CID 38518566.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

Zinner SH (November 2000). "Tourette disorder". Pediatr Rev (Review). 21 (11): 372–83. doi:10.1542/pir.21-11-372. PMID 11077021. S2CID 7774922.

Efron D, Dale RC (October 2018). "Tics and Tourette syndrome". J Paediatr Child Health (Review). 54 (10): 1148–53. doi:10.1111/jpc.14165. hdl:11343/284621. PMID 30294996. S2CID 52934981.

Stern JS (August 2018). "Tourette's syndrome and its borderland" (PDF). Pract Neurol (Historical review). 18 (4): 262–70. doi:10.1136/practneurol-2017-001755. PMID 29636375. S2CID 4709096.

Paschou P (July 2013). "The genetic basis of Gilles de la Tourette Syndrome". Neurosci Biobehav Rev (Review). 37 (6): 1026–39. doi:10.1016/j.neubiorev.2013.01.016. PMID 23333760. S2CID 10515751.

Robertson MM, Eapen V, Singer HS, et al. (February 2017). "Gilles de la Tourette syndrome". Nat Rev Dis Primers (Review). 3: 16097. doi:10.1038/nrdp.2016.97. PMID 28150698. S2CID 38518566.

Causes and origins of Tourette syndrome (English Wikipedia)

aafp.org

archive.org

bmj.com

pn.bmj.com

doi.org

handle.net

hdl.handle.net

medscape.com

emedicine.medscape.com

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

scielo.br

semanticscholar.org

api.semanticscholar.org

ucl.ac.uk

discovery.ucl.ac.uk

web.archive.org